Biotech · Private company · Lynnfield, MA, US
Ortholevo, Inc.
Track this companyFree. Adds Ortholevo, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- Late Stage Development of Sustained-release Relaxin for Treating Joint ContractureFiscal year 2026 · $490.3KNIH RePORTER 5SB1AR084380-03 · fetched Nov 12, 2026
- Late Stage Development of Sustained-release Relaxin for Treating Joint ContractureFiscal year 2025 · $504.6KNIH RePORTER 5SB1AR084380-02 · fetched Nov 12, 2026
- Late Stage Development of Sustained-release Relaxin for Treating Joint ContractureFiscal year 2024 · $505KNIH RePORTER 1SB1AR084380-01A1 · fetched Nov 12, 2026